SOURCES:
Colleen Krejewski, MD, assistant professor of Obstetrics, Gynecology, and Reproductive Sciences, University of Pittsburgh.
Sheila Chhutani, MD, OB-GYN, Texas Health Presbyterian Hospital Dallas.
Richard Kaye, MD, OB-GYN, Texas Health Presbyterian Hospital Plano.
American Congress of Obstetricians and Gynecologists, Committee Opinion: “Risk of Venous Thromboembolism Among Users of Drospirenone-Containing Oral Contraceptive Pills.”
Centers for Disease Control: Summary Chart of U.S. Medical Eligibility Criteria for Contraceptive Use.
FamilyDoctor.org: Progestin-Only Contraceptives.
National Cancer Institute: Oral Contraception and Cancer Risk.
Marchbanks, PA, Contraception, April 2012.
Bedsider.org: “What’s the Risk?”
FDA.gov: Depo-Provera Contraceptive injection (medroxyprogesterone acetate) injectable suspension
Berenson, A, American Journal of Obstetrics & Gynecology, March, 2009
American Congress of Obstetricians and Gynecologists, Committee Opinion: “Depot Medroxyprogesterone Acetate and Bone Effects”
Planned Parenthood: “IUD,” “When does an IUD start working?”
Association of Reproductive Health Professionals: “Health Matters Fact Sheets: Copper T IUD,” “Non-hormonal Contraceptive Methods,” “Methods Match.”
